Aika Miya

Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone

Kyu Yong Cho, Akinobu Nakamura, Kazuno Omori et al. · Journal of Diabetes Investigation · 2020 · 55 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial

Takahiro Takase, Akinobu Nakamura, Hiroshi Nomoto et al. · Journal of Diabetes Investigation · 2018 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)

Naoyuki Kitao, Hideaki Miyoshi, Tomoo Furumoto et al. · Cardiovascular Diabetology · 2017 · 41 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial

Aika Miya, Akinobu Nakamura, Hideaki Miyoshi et al. · Journal of Diabetes Investigation · 2017 · 35 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +16

Impact of Glucose Loading on Variations in CD4+ and CD8+ T Cells in Japanese Participants with or without Type 2 Diabetes

Aika Miya, Akinobu Nakamura, Hideaki Miyoshi et al. · Frontiers in Endocrinology · 2018 · 32 citations · Full text

Medicine, Endocrinology, Immunology +17